Jonathan Hirsch currently serves as the Chief Strategy and Growth Officer at Paradigm, focusing on creating equitable access to clinical trials for patients by streamlining physician participation. In addition to this role, Jonathan is a Co-Founder, Investor, and Chair of the Advisory Board at Synapticure Inc. and holds positions as a Seed Investor at Protege, an Investor at Arbital Health, Frame, and Thyme Care, as well as an Advisor at Viz.ai and a Strategic Advisor and Investor at Osmind. Jonathan is also a Partner at Rebel Fund. Educational credentials include a Master of Science in Biological Sciences from Stanford University and a Bachelor of Arts in Biology and Political Science from the University of Chicago.
This person is not in the org chart
This person is not in any teams
This person is not in any offices